- cafead   Apr 19, 2024 at 11:53: AM
via Alvotech and Teva Pharmaceuticals on Friday announced that they have signed a new long-term agreement with an undisclosed strategic partner in order to make its Humira biosimilar Simlandi (adalimumab-ryvk) more accessible to U.S. patients.
article source
article source